tiprankstipranks
Starpharma Director Bolsters Stake with On-Market Purchase
Company Announcements

Starpharma Director Bolsters Stake with On-Market Purchase

Starpharma Holdings Limited (AU:SPL) has released an update.

Dr. Russell Basser, a director at Starpharma Holdings Limited, has acquired 71,428 ordinary shares of the company on-market, at a total value of $10,002, amounting to $0.140 per share. This transaction, dated April 12, 2024, increased his direct shareholding in the company to 71,428 ordinary shares. The notice states that there were no interests in securities traded during a closed period requiring prior written clearance.

For further insights into AU:SPL stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskStarpharma Stake Reduced by Allan Gray Australia
TipRanks Australian Auto-Generated NewsdeskStarpharma Applies for New Securities Quotation
TipRanks Australian Auto-Generated NewsdeskStarpharma Director Bolsters Share Ownership
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!